Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Oncotarget|March 24, 2018
Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinomaMaria Fernanda Setúbal Destro Rodrigues, Luke Gammon, Muhammad M Rahman, et al.Journal of Virology|September 6, 2013
Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like propertiesMartin Hufbauer, Adrian Biddle, Cinzia Borgogna, et al.Cancer Research|June 21, 2011
Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferativeAdrian Biddle, Xiao Liang, Luke Gammon, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 30, 2014
Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitorsHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Bexarotene and erlotinib for aerodigestive tract cancerKonstantin H Dragnev, W Jeffrey Petty, Sumit Shah, et al.Journal of the National Cancer Institute|November 17, 2005
A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesisW Jeffrey Petty, Na Li, Adrian Biddle, et al.Stem Cells (Dayton, Ohio)|May 8, 2013
Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMMHideo Shigeishi, Adrian Biddle, Luke Gammon, et al.Pharmacology & Therapeutics|October 1, 2018
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomasMohit Kumar Jolly, Jason A Somarelli, Maya Sheth, et al.Cancers|November 13, 2025
Identification of Phenotypically Distinct Cancer Stem Cell Subpopulations in Oral Squamous Cell CarcinomaTarig Al-Hadi Osman, Oddveig Rikardsen, Muy-Teck Teh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancersW Jeffrey Petty, Konstantin H Dragnev, Vincent A Memoli, et al.Pageof 4